µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© /._wXH
C,w$)x5kls
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© \HDRr*KO
1¡¢Co-stimulators (or co-stimulating molecules) Frt_X %
2¡¢NK-kB PCs+`
WP!M
3¡¢Immunoglobulin superfamily #nc{MR#R
4¡¢antigen-presenting cell (APC) n-dO |3,
5¡¢death domain S5'BXE,
6¡¢CCR and CXCR 5isejR{r
7¡¢Lectin (or mitogen) Z-b^{uP
8¡¢Clusters of differentiation, CD) _EOQ*K#=Ct
9¡¢B7 family @7%nMTZ@&v
10¡¢Cytotoxic T lymphocyte, CTL) s} ,p>8
11¡¢IL-15 and IL-15 receptor (IL-15R) Vu
FH
>8n
12¡¢MHC restriction r9G<HKl
13¡¢Affinity-chromatography g!<@6\RB
14¡¢Cyctosprin A, CsA LZy
Ulz
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) A%u-6"
5-bd1
!o
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 9S.Uo[YY
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 }@}jwi)l
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ A[Juv]X
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 u
Y/Q]NT
8(D>ws$
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© uA:|#mO
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ c0u!V+V%
ѪҺ²¡Ñ§×¨Òµ£º $\$5::}r
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿